SCHEMBL7913159

SCHEMBL7913159

CCOC(=O)c1ccc(Sn2nc(-c3ccc(Cl)cc3)n(C3CC3)c2=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
MAPT P10636 4/20 0.42
HSD17B10 Q99714 2/20 0.42
TSHR P16473 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
USP2 O75604 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
HTT P42858 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
ALOX12 P18054 1/20 0.40
RECQL P46063 1/20 0.40
FDFT1 P37268 1/20 0.40
ELANE P08246 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16542302 0.81 LMNA (0.42) LMNAMAPTHSD17B10TSHRNPC1
SCHEMBL16167676 0.80 ALDH1A1 (0.47) LMNAMAPTPOLBSMN1; SMN2KDM4E
SCHEMBL3976537 0.75 LMNA (0.44) LMNAMAPTTSHRNPC1RAB9A
SCHEMBL8228870 0.75 TSHR (0.58) LMNAHSD17B10TSHRNPC1RAB9A
SCHEMBL7913999 0.74 ALDH1A1 (0.42) LMNAMAPTPOLBSMN1; SMN2MEN1
SCHEMBL4506900 0.73 LMNA (0.44) LMNAMAPTHSD17B10TSHRNPC1
SCHEMBL4491713 0.72 TSHR (0.54) LMNAMAPTHSD17B10TSHRNPC1
SCHEMBL7916915 0.70 HSD11B1 (0.40) LMNASMN1; SMN2ALDH1A1CNR1
SCHEMBL4499313 0.70 KDM4E (0.43) LMNAHSD17B10TSHRUSP2MEN1
SCHEMBL7480159 0.70 CA12 (0.61) LMNAMAPTHSD17B10TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010063402-A1 SUBSTITUTED BENZYL AND PHENYLSULFONYL TRIAZOLONES, AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-10 WO disclosed